Related Experiment Videos
p53 tumor-suppressor gene: clues to molecular carcinogenesis
1Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-4255, USA.
Abstract:
The tumor-suppressor gene product p53 is clearly a component in several biochemical pathways, including transcription, DNA repair, genomic stability, cell-cycle control and apoptosis, that are central to human carcinogenesis. The p53 is functionally inactivated by mutational, viral, and cellular mechanisms in the majority of human cancers. Analysis of the spectrum of p53 mutations provides clues to the etiology and molecular pathogenesis of cancer. Recent insight into the p53-mediated biochemical pathways of cell-cycle arrest and apoptosis has provided further understanding of the mechanisms related to p53-mediated tumor suppression. This insight in turn may provide the potential molecular targets for the development of rational multimodality cancer therapy, including chemo-, immuno-, and gene-therapeutic strategies. The convergence of previously parallel lines of basic, clinical, and epidemiologic investigation may provide an opportunity to transfer research findings rapidly from the laboratory to the clinic.
Insights
The tumor-suppressor p53 protein is crucial for preventing cancer by regulating cell growth and death. Its inactivation is common in cancers, offering targets for new therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p53 protein is a key tumor suppressor involved in critical cellular processes like DNA repair and apoptosis.
- Functional inactivation of p53 occurs in most human cancers through various mechanisms.
- Understanding p53's role is vital for cancer etiology and pathogenesis research.
Purpose of the Study:
- To explore the biochemical pathways regulated by p53.
- To investigate the mechanisms of p53 inactivation in cancer.
- To identify potential therapeutic targets based on p53's function.
Main Methods:
- Analysis of p53 mutation spectrum in human cancers.
- Investigation of p53-mediated cell-cycle arrest and apoptosis pathways.
- Review of current research on p53's role in carcinogenesis.
Main Results:
- p53 mutations provide insights into cancer causes and development.
- p53 regulates transcription, DNA repair, genomic stability, cell-cycle control, and apoptosis.
- Inactivation of p53 is a common event in human cancers.
Conclusions:
- p53 is a central player in tumor suppression.
- Understanding p53 pathways can lead to novel cancer therapies.
- Integrating basic, clinical, and epidemiological research can accelerate clinical translation.